Intellia Therapeutics's total assets for Q2 2026 were $857.16M, an increase of 12.97% from the previous quarter. DE:38I total liabilities were $129.46M for the fiscal quarter, a -6.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.